Sotera Health — Third Quarter 2026 Earnings Summary

Sotera Health reported third-quarter 2026 net revenues of $324.9 million, representing a 4.4% increase compared to the same period in 2025. The company achieved net income of $58.4 million, or $0.20 per diluted share, while Adjusted EBITDA rose 3.9% to $170.7 million. Segment performance varied, with Sterigenics and Nelson Labs posting constant currency revenue growth of 8.2% and 9.2% respectively, while Nordion revenues declined 11.5% due to Cobalt-60 harvest timing. Sotera Health reaffirmed its full-year 2026 outlook, projecting net revenue growth of 5.25% to 6.75% and Adjusted EBITDA growth of 5.75% to 7.25% on a constant currency basis.